全文获取类型
收费全文 | 1693篇 |
免费 | 113篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 27篇 |
儿科学 | 32篇 |
妇产科学 | 23篇 |
基础医学 | 271篇 |
口腔科学 | 39篇 |
临床医学 | 97篇 |
内科学 | 439篇 |
皮肤病学 | 43篇 |
神经病学 | 157篇 |
特种医学 | 40篇 |
外科学 | 224篇 |
综合类 | 8篇 |
预防医学 | 72篇 |
眼科学 | 50篇 |
药学 | 120篇 |
中国医学 | 10篇 |
肿瘤学 | 167篇 |
出版年
2024年 | 2篇 |
2023年 | 21篇 |
2022年 | 55篇 |
2021年 | 92篇 |
2020年 | 49篇 |
2019年 | 52篇 |
2018年 | 61篇 |
2017年 | 48篇 |
2016年 | 54篇 |
2015年 | 42篇 |
2014年 | 68篇 |
2013年 | 84篇 |
2012年 | 154篇 |
2011年 | 132篇 |
2010年 | 86篇 |
2009年 | 41篇 |
2008年 | 113篇 |
2007年 | 81篇 |
2006年 | 102篇 |
2005年 | 103篇 |
2004年 | 100篇 |
2003年 | 73篇 |
2002年 | 76篇 |
2001年 | 22篇 |
2000年 | 20篇 |
1999年 | 9篇 |
1998年 | 10篇 |
1997年 | 9篇 |
1996年 | 8篇 |
1995年 | 6篇 |
1994年 | 2篇 |
1993年 | 7篇 |
1992年 | 6篇 |
1991年 | 1篇 |
1990年 | 5篇 |
1989年 | 2篇 |
1988年 | 5篇 |
1987年 | 2篇 |
1985年 | 3篇 |
1984年 | 1篇 |
1983年 | 2篇 |
1979年 | 3篇 |
1978年 | 3篇 |
1975年 | 2篇 |
1974年 | 1篇 |
1964年 | 1篇 |
排序方式: 共有1819条查询结果,搜索用时 15 毫秒
51.
52.
Numata A Fujimaki K Aoshima T Onizuka M Hagihara M Miyazaki K Fujita H Sakai R Machida S Tanaka E Nakajima Y Hattori Y Tanaka M Yamazaki E Shirasugi Y Inoue Y Watanabe S Fujisawa S 《[Rinshō ketsueki] The Japanese journal of clinical hematology》2012,53(7):698-704
We conducted a retrospective study to evaluate outcomes and prognostic factors of newly diagnosed patients with t(8;21) acute myeloid leukemia (AML). There were 70 patients (43 men and 27 women) with a median age of 48 years old (range, 17~76 years old). Sixty-five patients achieved complete remission (CR) after induction chemotherapy. Fifty-seven patients received consolidation chemotherapy based on the policy of not performing allogeneic hematopoietic stem cell transplantation (allo-HSCT) at the time of first CR. Twenty-seven of the 57 patients relapsed (relapse rate, 47%). The median time from the achievement of the first CR to relapse was 307 days (96~1,256 days). A white blood cell count of more than 25,400/μl at diagnosis was associated with a higher relapse rate than a white blood cell count of less than or equal to 25,400/μl (75% vs. 43%, P=0.04). Nineteen of the 25 relapsed patients who received re-induction therapy experienced a second CR (second CR rate, 76%). Twenty-six patients (5 with first CR, 12 with second CR, and 9 without remission) received allo-HSCT. The five-year overall survival and disease-free survival rates were 61% and 45%, respectively. Patients with t(8;21) AML had a high CR rate, but about half of them relapsed. However, this report could not show prognostic factors for the identification of patients who should receive allo-HSCT at the time of their first CR. 相似文献
53.
Ishizawa J Mori T Tsukada Y Matsuki E Yokoyama K Shimizu T Sugita K Murata M Iwata S Okamoto S 《[Rinshō ketsueki] The Japanese journal of clinical hematology》2012,53(6):623-627
A 62-year-old man with diffuse large B-cell lymphoma received five courses of R-CHOP chemotherapy. The patient developed cellulitis in the bilateral lower extremities without fever, and blood culture yielded Helicobacter cinaedi after five-day culture. Although the response to tazobactam/piperacillin (TAZ/PIPC) was prompt, cellulitis recurred immediately after discontinuation of the drug. Even after two months of treatment with PIPC plus amikacin followed by amoxicillin, it recurred again soon after stopping the antibiotics. H. cinaedi reportedly causes bacteremia and cellulitis in immunocompromised patients mostly in patients with acquired immunodeficiency syndrome. Only sporadic cases have been reported in association with hematological malignancies. Physicians should be aware of H. cinaedi as one of the causative pathogens of bacteremia and cellulitis in patients with hematological malignancies. Longer incubation period of blood culture is needed to detect the microbe and long-term use of antimicrobials is required to prevent recurrent cellulitis. 相似文献
54.
Yokoo E Tsuji T Yamasaki H Tsuda H 《[Rinshō ketsueki] The Japanese journal of clinical hematology》2012,53(5):543-545
A previously healthy 59-year-old woman was admitted to our hospital due to petechiae. Investigations showed profound thrombocytopenia (1.5×10(4)/μl) and mild elevation of transaminases. The serological examination revealed acute cytomegalovirus (CMV) infection. We intermittently measured CMV load in her clinical course. The petechiae improved with no therapy. One month later, the platelet count was increased up to 7.6×10(4)/μl and CMV-DNA was reduced to undetectable levels. CMV-induced thrombocytopenia in an immunocompetent adult is rare. We also recognized the association of platelet counts and virus load in the natural course of this patient with CMV-induced thrombocytopenia. 相似文献
55.
56.
Tomoki Ueda Rioko Iino Kenji Yokoyama Shinichiro Okamoto Keiko Asakura Yuiko Tsukada Jo Ishizawa Eri Matsuki Yasuo Ikeda Yutaka Hattori 《International journal of hematology》2012,96(4):477-484
In order to test for improved survival following autologous transplantation (ASCT), we conducted a prospective clinical trial of post-ASCT thalidomide therapy in Japanese patients with multiple myeloma (MM). Twenty-five newly diagnosed patients received double or single ASCT with high-dose melphalan (200?mg/m2). Two months after stem cell infusion, if the patients failed to achieve a near-complete response, thalidomide was administered at 200?mg/day until disease progression or occurrence of intolerable adverse events. Seventeen patients were in partial response or minimal response after ASCT and received thalidomide alone. Their median progression-free survival (PFS) from ASCT was 17.4?months, and the median overall survival (OS) was 42.9?months. Some patients with normal karyotype experienced durable disease stabilization for over 5?years. Five patients who exhibited high-risk chromosomal changes such as t(4;14) or deletion of chromosome 13 or 17 showed very short PFS and OS compared with those who did not. Observed grade 3 or 4 toxicities included infection in three patients, hematological toxicities in three, and gastrointestinal toxicities in two, but there was no grade 3 or higher peripheral neuropathy, probably due to appropriate dose modifications. This long-term prospective study is the first to demonstrate the feasibility of post-ASCT thalidomide therapy in Japanese patients with MM. 相似文献
57.
Hirakawa E Saito K Hirata S Atsumi T Koike T Tanaka Y 《Modern rheumatology / the Japan Rheumatism Association》2012,22(5):769-773
A 16-year-old male with severe thrombocytopenia and progressive multiple organ infarctions was diagnosed as having catastrophic antiphospholipid syndrome (CAPS) complicated with systemic lupus erythematosus, and was successfully treated with combination of anticoagulants, corticosteroids, plasma exchange, and intravenous cyclophosphamide. Antibodies to phosphatidylserine/prothrombin (PS/PT) complex and cardiolipin (CL)/β(2)-glycoprotein?I (β(2)GPI) were simultaneously detected, indicating that the different pathways of both PS/PT and CL/β(2)GPI might be associated with the radical manifestation of CAPS. 相似文献
58.
Tetsu?AkimotoEmail author Hiromichi?Yoshizawa Yuko?Watanabe Akihiko?Numata Tomoyuki?Yamazaki Eri?Takeshima Kana?Iwazu Takanori?Komada Naoko?Otani Yoshiyuki?Morishita Chiharu?Ito Kazuhiro?Shiizaki Yasuhiro?Ando Shigeaki?Muto Makoto?Kuro-o Eiji?Kusano 《BMC nephrology》2012,13(1):155
Background
Klotho is a single-pass transmembrane protein, which appears to be implicated in aging. The purpose of the present study was to characterize the relationship between the soluble Klotho level and renal function in patients with various degrees of chronic kidney disease (CKD).Methods
The levels of soluble Klotho in the serum and urine obtained from one hundred thirty-one CKD patients were determined by a sandwich enzyme-linked immunosorbent assay system.Results
The amount of urinary excreted Klotho during the 24 hr period ranged from 1.6 to 5178 ng/day (median 427 ng/day; interquartile range [IR] 56.8-1293.1), and the serum Klotho concentration ranged from 163.9 to 2123.7 pg/ml (median 759.7 pg/ml; IR 579.5-1069.1). The estimated glomerular filtration rate (eGFR) was significantly correlated with the log-transformed values of the amount of 24 hr urinary excreted Klotho (r?=?0.407, p?<?0.01) and the serum Klotho levels (r?=?0.232, p?<?0.01). However, a stepwise multiple regression analysis identified eGFR to be a variable independently associated only with the log-transformed value of the amount of 24-hr urinary excreted Klotho but not with the log-transformed serum Klotho concentration. Despite the strong correlation between random urine protein-to-creatinine ratio and the 24 hr urinary protein excretion (r?=?0.834, p?<?0.01), a moderate linear association was observed between the log-transformed value of the amount of 24 hr urinary excreted Klotho and that of the urinary Klotho-to-creatinine ratio (Klotho/Cr) in random urine specimens (r?=?0.726, p?<?0.01).Conclusions
The amount of urinary Klotho, rather than the serum Klotho levels, should be linked to the magnitude of the functioning nephrons in CKD patients. The use of random urine Klotho/Cr as a surrogate for the amount of 24-hr urinary excreted Klotho needs to be evaluated more carefully.59.
Mase Kaori Saito Chie Usui Joichi Arimura Yoshihiro Nitta Kosaku Wada Takashi Makino Hirofumi Muso Eri Hirawa Nobuhito Kobayashi Masaki Yumura Wako Fujimoto Shouichi Nakagawa Naoki Ito Takafumi Yuzawa Yukio Matsuo Seiichi Yamagata Kunihiro 《Clinical and experimental nephrology》2022,26(11):1092-1099
Clinical and Experimental Nephrology - The life prognosis of elderly patients with myeloperoxidase–anti-neutrophil cytoplasmic antibodies-associated vasculitis (MPO-AAV) has been improved by... 相似文献
60.
Pharmacodynamic Actions of a Long‐Acting PTH Analog (LA‐PTH) in Thyroparathyroidectomized (TPTX) Rats and Normal Monkeys
下载免费PDF全文
![点击此处可从《Journal of bone and mineral research》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Masaru Shimizu Eri Joyashiki Hiroshi Noda Tomoyuki Watanabe Makoto Okazaki Miho Nagayasu Kenji Adachi Tatsuya Tamura John T Potts Jr Thomas J Gardella Yoshiki Kawabe 《Journal of bone and mineral research》2016,31(7):1405-1412
Hypoparathyroidism is a disease of chronic hypocalcemia and hyperphosphatemia due to a deficiency of parathyroid hormone (PTH). PTH and analogs of the hormone are of interest as potential therapies. Accordingly, we examined the pharmacological properties of a long‐acting PTH analog, [Ala1,3,12,18,22, Gln10,Arg11,Trp14,Lys26]‐PTH(1‐14)/PTHrP(15‐36) (LA–PTH) in thyroparathyroidectomized (TPTX) rats, a model of HP, as well as in normal monkeys. In TPTX rats, a single intravenous administration of LA‐PTH at a dose of 0.9 nmol/kg increased serum calcium (sCa) and decreased serum phosphate (sPi) to near‐normal levels for longer than 48 hours, whereas PTH(1‐34) and PTH(1‐84), each injected at a dose 80‐fold higher than that used for LA‐PTH, increased sCa and decreased sPi only modestly and transiently (<6 hours). LA‐PTH also exhibited enhanced and prolonged efficacy versus PTH(1‐34) and PTH(1‐84) for elevating sCa when administered subcutaneously (s.c.) into monkeys. Daily s.c. administration of LA‐PTH (1.8 nmol/kg) into TPTX rats for 28 days elevated sCa to near normal levels without causing hypercalciuria or increasing bone resorption markers, a desirable goal in the treatment of hypoparathyroidism. The results are supportive of further study of long‐acting PTH analogs as potential therapies for patients with hypoparathyroidism. © 2016 American Society for Bone and Mineral Research. 相似文献